SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-372224
Filing Date
2017-12-18
Accepted
2017-12-18 17:02:09
Documents
6
Period of Report
2017-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d492785d8k.htm 8-K 22303
2 EX-10.1 d492785dex101.htm EX-10.1 472982
3 EX-10.2 d492785dex102.htm EX-10.2 37958
4 EX-99.1 d492785dex991.htm EX-99.1 19699
5 GRAPHIC g492785g1212050323777.jpg GRAPHIC 1925
6 GRAPHIC g492785g1212050323871.jpg GRAPHIC 2222
  Complete submission text file 0001193125-17-372224.txt   560070
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 171262042
SIC: 2836 Biological Products, (No Diagnostic Substances)